CELLMATES ON THE RUN FOUNDATION

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2016

Legal Domicile

Phone

3125471105

Tax Period

2024-01-01 to 2024-12-31

CELLMATES ON THE RUN FOUNDATION, founded in 2016, is a small nonprofit in the Medical Research sector that reported $351K in total revenue in fiscal year 2024. Expenses of $799K exceeded revenue, resulting in a 128% operating deficit.

Mission

Support a global collaboration of research scientists to functionally cure diabetes.

Program Service Accomplishments

Program 1

Expenses: $761,498 Revenue: $350,759

Support research scientists and physicians to functionally cure diabetes. In 2023, an important goal was achieved, the FDA approved allogenic islet transportation as a treatment option for brittle...

Support research scientists and physicians to functionally cure diabetes. In 2023, an important goal was achieved, the FDA approved allogenic islet transportation as a treatment option for brittle type I diabetes. The next goal is to test encapsulated islets so that no long-term immunosuppression is needed. In tandem, we support the development of an unlimited source of glucose responsive insulin secreting cells. In addition, the foundation raises awareness of type I diabetes through events and assists in the purchase of research equipment.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $316,873

Program Service Revenue $0

Investment Income $33,886

Other Revenue $0

TOTAL REVENUE $350,759

Expense Breakdown

Grants Paid $621,717

Salaries & Benefits $68,150

Fundraising Expenses $835

Program Expenses $761,498

Other Expenses $109,611

TOTAL EXPENSES $799,478

Year-over-Year Comparison

	2024	2023	Change
Revenue	$350,759	$329,800	+0.1%
Expenses	$799,478	$889,263	-0.1%
Net Income	$-448,719	$-559,463	-0.2%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Brigitte Oberholzer	Director	2.00	Director	$0	$0	$0
John Dine	Director	2.00	Director	$0	$0	$0
Amy Cogswell	Director	2.00	Director	$0	$0	$0
Jill Dine	Executive Director	2.00	Officer Director	$0	$0	$0
Helen Jung	Treasurer	0.00	Officer Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	No data	No data	No data	No data
2024	$350,759	$799,478	$2,590,696	$-448,719
2023	$329,800	$889,263	$3,154,976	$-559,463
2022	$1,249,704	$336,162	$3,594,170	$913,542
2021	$382,931	$172,268	$2,679,980	$210,663
2020	$273,228	$421,721	$2,491,654	$-148,493
2019	$695,988	$385,464	$2,619,999	$310,524
2018	$1,589,182	$547,510	$2,306,408	$1,041,672